When Immunization Leads to Autoimmunity: Chronic Inflammation as a Result of Thymic and Mucosal Dysregulation in IL-2 Knock-out Mice

References

• Wheelock E. F. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 1965; 149: 310
   Web of Science ®Google Scholar
• Gotoff S. P. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis. J. Lab. Clin. Med. 1973; 82(4)682–91
   Google Scholar
• Grey I., Rk G., Waksman B. Potentiation of T-lymphocyte responses to mitogens. I. The responding cell. J. Exp. Med. 1972; 136: 128
   Google Scholar
• Valentine F. T. Soluble factors produced by lymphocytes. Ann. N. Y. Acad. Sci. 1974; 221: 317–23
   Google Scholar
• Walker S. M., Lucas Z. J. Cytotoxic activity of lymphocytes. IV. Preparation of heterologous antibody to human lymphotoxin. J. Immunol. 1974; 113(3)813–23
   Google Scholar
• Messner R. P., Granger G. A. Clinical aspects of T- and B-lymphocytes in rheumatic diseases. Lymphokines - the mediators of cellular immunity. Arthritis Rheum. 1974; 17(4)339–46
   Google Scholar
• Amino N. Human lymphotoxin obtained from established lymphoid lines: purification characteristics and inhibition by anti-immunoglobulin. J. Immunol. 1974; 113(4)1334–45
   Google Scholar
• Morgan D., Ruscetti F., Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrow. Science 1976; 193: 1007
   PubMed Web of Science ®Google Scholar
• Gillis S., Ka S. Long-term culture of cytotoxic T-lymphocytes. Nature 1977; 268: 154
   PubMed Web of Science ®Google Scholar
• Gillis S., Smith K. A. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells. J. Exp. Med. 1977; 146(2)468–82
   Google Scholar
• Gillis S. Long term culture of tumour-specific cytotoxic T cells [letter] T-cell growth factor-mediated T-cell proliferation. Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. Nature 1977; 268(5616)154–6
   PubMed Web of Science ®Google Scholar
• Baker P. E. The effect of T cell growth factor on the generation of cytolytic T cells. J. Immunol. 1978; 121(6)2168–73
   Google Scholar
• Holbrook N. J. T-cell growth factor: complete nucleotide sequence and organization of the gene in normal and malignant cells. Proc. Natl. Acad. Sci. USA 1984; 81(6)1634–8
   Google Scholar
• Taniguchi R. Structure and expression of a cloned cDNA for human interleukin-2. Nature 1983; 302: 305
   PubMed Web of Science ®Google Scholar
• Smith K. A., Favata M. F., Oroszlan S. Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J. Immunol. 1983; 131(4)1808–15
   PubMed Web of Science ®Google Scholar
• Robb R. J., Munck A., Smith K. A. T cell growth factor receptors. Quantitation, specificity, and biological relevance. J. Exp. Med. 1981; 154(5)1455–74
   PubMedGoogle Scholar
• Perussia B. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat. Immun. Cell Growth Regul. 1987; 6(4)171–88
   Google Scholar
• Perussia B. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+T lymphocytes, and NK cells. J. Immunol. 1992; 149(11)3495–502
   Google Scholar
• Wagner H. The in vivo effects of interleukin 2 (TCGF). Immunobiology 1982; 161(1–2)139–56
   Google Scholar
• Cohen F. E. Structure-activity studies of interleukin-2. Science 1986; 234(4774)349–52
   Google Scholar
• Smith K. A. Interleukin-2: inception, impact, and implications. Science 1988; 240(4856)1169–76
   PubMed Web of Science ®Google Scholar
• Kramer M. D., Koszinowski U. H. Regulatory counteraction to IL-2 activity. Lymphokine Res. 1983; 2(3)77–82
   Google Scholar
• Muraguchi A. Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J. Exp. Med. 1985; 161(1)181–97
   Google Scholar
• Toribio M. L. Interleukin-2-dependent autocrine proliferation in T-cell development. Nature 1989; 342(6245)82–5
   Google Scholar
• Gerosa F. Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells. Cell Immunol. 1993; 150(2)382–90
   Google Scholar
• Kundig T. M. Immune responses in interleukin-2-deficient mice. Science 1993; 262(5136)1059–61
   Google Scholar
• Sadlack B. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene (see comments). Cell 1993; 75(2)253–61
   PubMed Web of Science ®Google Scholar
• Willerford D. M. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995; 3(4)521–30
   PubMed Web of Science ®Google Scholar
• Suzuki H. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995; 268(5216)1472–6
   PubMed Web of Science ®Google Scholar
• Miller J. F., Flavell R. A. T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance. Curr. Opin. Immunol. 1994; 6(6)892–9
   Google Scholar
• Sprent J. The thymus and T-cell tolerance. Ann. N. Y. Acad. Sci. 1993; 681: 5–15
   PubMed Web of Science ®Google Scholar
• Suda T. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes. J. Immunol. 1990; 144(8)3039–45
   Google Scholar
• Suda T. Identification of a novel thymocyte growth-promoting factor derived from B cell lymphomas. Cell Immunol. 1990; 129(1)228–40
   Google Scholar
• Zlotnik A. Cytokine production by mature and immature CD4—CD8-T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. J. Immunol. 1992; 149(4)1211–5
   Google Scholar
• Godfrey D. I., Zlotnik A. Control points in early T-cell development. Immunol. Today 1993; 14(11)547–53
   PubMedGoogle Scholar
• Lowenthal J. W. Antigenic stimulation regulates the expression of IL 2 receptors in a cytolytic T lymphocyte clone. J. Immunol. 1985; 134(2)931–9
   Google Scholar
• Robb R. J., Greene W. C., Rusk C. M. Low and high affinity cellular receptors for interleukin 2. Implication for the level of Tac antigen. J. Exp. Med. 1984; 160: 1126
   PubMed Web of Science ®Google Scholar
• Shimonkevitz R. P. Transient expression of IL-2 receptor precedes the differentiation of immature thymocytes. Nature 1987; 329(6135)157–9
   Google Scholar
• Ceredig R. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 1985; 314: 98
   PubMed Web of Science ®Google Scholar
• Raulet D. H. Expression and function of interleukin-2 receptors on immature thymocytes. Nature 1985; 314: 101
   PubMedGoogle Scholar
• Skinner M., Marbrook J. Effect of interleukin 2 on fetal thymocytes in organ cultures: generation of lymphokine-activated killer cells. Cell Immunol. 1988; 112(1)104–11
   Google Scholar
• de la Hera A. Interleukin 2 promotes growth and cytolytic activity in human T3+ 4–8- thymocytes. Proc. Natl. Acad. Sci. USA 1985; 82(18)6268–71
   Google Scholar
• Toribio M. L. Activation of the interleukin 2 pathway precedes CD3-T cell receptor expression in thymic development. Differential growth requirements of early and mature intrathymic subpopulations. Eur. J. Immunol. 1989; 19(1)9–15
   Google Scholar
• Jenkinson E. J., Kingston R., Owen J. J. Importance of IL-2 receptors in intrathymic generation of cells expressing T-cell receptors. Nature 1987; 329(6135)160–2
   Google Scholar
• Bendelac A. Activation events during thymic selection. J. Exp. Med. 1992; 175(3)731–42
   Google Scholar
• Toribio M. L. Involvement of the interleukin 2 pathway in the rearrangement and expression of both alpha/beta and gamma/delta T cell receptor genes in human T cell precursors. J. Exp. Med. 1988; 168(6)2231–49
   Google Scholar
• Chen D., Rothenberg E. V. Molecular basis for developmental changes in interleukin-2 gene inducibility. Mol. Cell. Biol. 1993; 13(1)228–37
   PubMedGoogle Scholar
• Takeuchi Y. Expression and role of interleukin-2 receptor beta chain on CD4-CD8- T cell receptor alpha beta+ cells (corrected) (published erratum appears in Eur. J. Immunol. 1993; 23(1)311, Eur. J. Immunol. 1992 22 (11) 2929–35
   Google Scholar
• Reem G. H. Induction and upregulation by interleukin 2 of high-affinity interleukin 2 receptors on thymocytes and T cells. Proc. Natl. Acad. Sci. USA 1985; 82(24)8663–6
   Google Scholar
• Tentori L. Essential role of the interleukin 2-interleukin 2 receptor pathway in thymocyte maturatio in vivo. J. Exp. Med. 1988; 168(5)1741–7
   Google Scholar
• Chang J. F., Thomas C. A. D., Kung J. T. Mitogen-induced IL-2 production and proliferation at defined stages of T helper cell development. J. Immunol. 1991; 147(3)860–6
   Google Scholar
• Gotlieb W. H. Selective stimulation of thymocyte precursors mediated by specific cytokines. Different CD3+ subsets are generated by IL-1 versus IL-2. J. Immunol. 1991; 146(7)2262–71
   Google Scholar
• Page D. M. TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. The Journal of Immunology 1998; 160: 120–133
   PubMedGoogle Scholar
• Horak I. Immunodeficiency in IL-2-knockout mice. Clin. Immunol. Immunopathol. 1995; 76(3)S172–3, Pt 2
   Google Scholar
• Hanke T. Induction of interleukin 2 receptor beta chain expression by self-recognition in the thymus. J. Exp. Med. 1994; 180(5)1629–36
   Google Scholar
• Schorle H. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991; 352(6336)621–4
   PubMed Web of Science ®Google Scholar
• Ehrhardt R. O. Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol. 1997; 158(2)566–73
   Google Scholar
• Sadlack B. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 1995; 25(11)3053–9
   PubMed Web of Science ®Google Scholar
• Ludviksson B. R. Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes. J. Immunol. 1997; 158(1)104–11
   Google Scholar
• Samoilova E. B. B7 blockade prevents activation-induced cell death of thymocytes. Int. Immunol. 1997; 9(11)1663–8
   Google Scholar
• Kishimoto H. Differing roles for B7 and intercellular adhesion molecule-1 in negative selection of thymocytes (see comments). J. Exp. Med. 1996; 184(2)531–7
   Google Scholar
• Punt J. A. Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J. Exp. Med. 1994; 179(2)709–13
   Google Scholar
• Kramer S., Schimpl A., Hunig T. Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J. Exp. Med. 1995; 182(6)1769–76
   PubMed Web of Science ®Google Scholar
• Lenardo M. J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991; 353(6347)858–61
   PubMed Web of Science ®Google Scholar
• Lerner A. Cross-linking of T-cell receptors on double-positive thymocytes induces a cytokine-mediated stromal activation process linked to cell death. EMBO. J. 1996; 15(21)5876–87
   Google Scholar
• Kneitz B. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur. J. Immunol. 1995; 25(9)2572–7
   Google Scholar
• Fournel S. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol. 1996; 157(10)4309–15
   Google Scholar
• Kramer S. Thymic selection and peptide-induced activation of T cell receptor-transgenic CD8 T cells in interleukin-2-deficient mice. Eur. J. Immunol. 1994; 24(10)2317–22
   Google Scholar
• Saijo K. Crucial role of Jak3 in negative selection of self-reactive T cells. J. Exp. Med. 1997; 185(2)351–6
   Google Scholar
• Hollander G. A. Severe colitis in mice with aberrant thymic selection. Immunity 1995; 3(1)27–38
   Google Scholar
• Hornquist C. E. G(alpha)i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J. Immunol. 1997; 158(3)1068–77
   Google Scholar
• Duchmann R. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) (see comments). Clin. Exp. Immunol. 1995; 102(3)448–55
   PubMed Web of Science ®Google Scholar
• Duchmann R. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol 1996; 26(4)934–8
   PubMed Web of Science ®Google Scholar
• Foo M. C., Lee A. Antigenic cross-reaction between mouse intestine and a member of the autochthonous microflora. Infect Immun. 1974; 9(6)1066–9
   Google Scholar
• Berg R. D., Savage D. C. Immune responses of specific pathogen-free and gnotobiotic mice to antigens of indigenous and nonindigenous microorganisms. Infect Immun. 1975; 11(2)320–9
   Google Scholar
• Yamada T. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology 1993; 104(3)759–71
   Google Scholar
• Sartor R. B., Rath H. C., Sellon R. K. Microbial factors in chronic intestinal inflammation. Current Opinion in Gastroenterology 1996; 12: 327–333
   Web of Science ®Google Scholar
• Thayer W. R., Chitnavis V. Inflammatory bowel disease. The case for an infectious etiology. Med. Clin. North Am. 1994; 78(6)1233–47
   Google Scholar
• Sartor R. B. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol. Clin. North Am. 1995; 24(3)475–507
   PubMed Web of Science ®Google Scholar
• Koutroubakis I. Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology 1996; 43(8)381–93
   PubMedGoogle Scholar
• Bayless T. M. Crohn's disease: concordance for site and clinical type in affected family members - potential hereditary influences (see comments). Gastroenterology 1996; 111(3)573–9
   PubMed Web of Science ®Google Scholar
• Hugot J. P. Mapping of a susceptibility locus for Crohn's disease on chromosome 16 (see comments). Nature 1996; 379(6568)821–3
   PubMed Web of Science ®Google Scholar
• Parkes M. Susceptibility loci in inflammatory bowel disease (letter). Lancet 1996; 348(9041)1588
   Google Scholar
• Satsangi J. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat. Genet. 1996; 14(2)199–202
   Google Scholar
• Bouma G. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD). Clin. Exp. Immunol. 1997; 109(1)175–9
   Google Scholar
• Pirzer U. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet 1991; 338(8777)1238–9
   Google Scholar
• Kuhn R. Interleukin-10-deficient mice develop chronic enterocolitis (see comments). Cell 1993; 75(2)263–74
   PubMed Web of Science ®Google Scholar
• Schultz M. IL-2 deficient mice raised under germ-free conditions develop delayed mild focal intestinal inflammation and progressive loss of B cells. Gastroenterology 1997; 112: 1086
   Google Scholar
• Mombaerts P. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice (see comments). Cell 1993; 75(2)274–82
   Google Scholar
• Mizoguchi A. Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J. Exp. Med. 1996; 184(2)707–15
   PubMed Web of Science ®Google Scholar
• Morrissey P. J., Charrier K. Induction of wasting disease in SCID mice by the transfer of normal CD4+/CD45RBhi T cells and the regulation of this auto-reactivity by CD4+/CD45RBlo T cells. Res. Immunol. 1994; 145(5)357–62
   Google Scholar
• Aranda R. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J. Immunol. 1997; 158(7)3464–73
   PubMed Web of Science ®Google Scholar
• Cahill R. J. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect. Immun. 1997; 65(8)3126–31
   PubMed Web of Science ®Google Scholar
• Ward J. M. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab. Anim. Sci. 1996; 46(1)15–20
   Google Scholar
• Rath H. C. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J. Clin. Invest. 1996; 98(4)945–53
   PubMed Web of Science ®Google Scholar
• Taurog J. D. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 1994; 180(6)2359–64
   PubMed Web of Science ®Google Scholar
• Mashimo H. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor (see comments). Science 1996; 274(5285)262–5
   PubMed Web of Science ®Google Scholar
• Shull M. M. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359(6397)693–9
   PubMed Web of Science ®Google Scholar
• Baribault H. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 1994; 8(24)2964–73
   Google Scholar
• Watanabe M. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J. Exp. Med. 1998; 187(3)389–402
   Google Scholar
• Hermiston M. L., Gordon J. I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995; 270(5239)1203–7
   PubMed Web of Science ®Google Scholar
• Hausmann S., Wucherpfennig K. W. Activation of autoreactive T cells by peptides from human pathogens. Curr. Opin. Immunol. 1997; 9(6)831–8
   PubMed Web of Science ®Google Scholar
• Segal B. M., Klinman D. M., Shevach E. M. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J. Immunol. 1997; 158(11)5087–90
   Google Scholar
• Trembleau S. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today. 1995; 16(8)383–6
   Google Scholar
• Simpson S. J. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur. J. Immunol 1995; 25(9)2618–25
   Google Scholar
• Rudolph U. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat. Genet. 1995; 10(2)143–50
   Google Scholar
• Neurath M. F. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 1995; 182(5)1281–90
   PubMed Web of Science ®Google Scholar
• Powrie F., Leach M. W., Mauze S., Menon S., Barcomb L., CaddieCoffman R. L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1994; 1: 553–562
   PubMed Web of Science ®Google Scholar
• Mizoguchi E., Mizoguchi A., Bhan A. K. Role of cytokines in the early stages of chronic colitis in TCR alpha- mutant mice. Lab. Invest. 1997; 76(3)385–97
   Google Scholar
• Desreumaux P. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 1997; 113(1)118–26
   PubMed Web of Science ®Google Scholar
• Parronchi P. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 1997; 150(3)823–32
   PubMed Web of Science ®Google Scholar
• Fuss I. J. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 1996; 157(3)1261–70
   PubMed Web of Science ®Google Scholar
• Niessner M., Volk B. A. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 1995; 101(3)428–35
   Google Scholar
• Breese E. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78(1)127–31
   PubMed Web of Science ®Google Scholar
• Karttunnen R. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation. J. Clin. Pathol. 1994; 47(11)1015–8
   Google Scholar
• Targan S. R. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N. Engl. J. Med. 1997; 337(15)1029–35
   PubMed Web of Science ®Google Scholar
• Sandborn W. J. A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease. Gastroenterology 1997; 113(3)1042–3
   Google Scholar